MRX vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
MRX
CME
Investment Advisor Scores
CME
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MRX | CME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.1891 | 21.9298 | MRX |
| PEG Ratio | 0 | 4.7092 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 32.1% | 0.8% | MRX |
| Earnings Growth | 105.3% | 2.5% | MRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.5/100 | 32.8/100 | MRX |
| Profit Margin | 12.2% | 63.4% | CME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | MRX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MRX
NeutralMixed signals - no dominant trend phase, RSI 43
CME
MarkupPrice above SMA50, rising 50-day trend (3.0% over 20 days), RSI 78
Fundamentals Snapshot
| Metric | MRX | CME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.3 | 23.4 |
| Trailing P/E | 14.5 | 25.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.0% |
| Gross Margin | 0.7% | 1.0% |
| Operating Margin | 0.2% | 0.7% |
| EPS | 4.95 | 11.79 |
| Dividend Yield | 0.01% | 0.02% |